85
Growth Score
pts
Heat Score
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
10913
Biogen is a biotechnology company engaged in the development of innovative therapies for neurological and neurodegenerative diseases.
- Adam Keeney: EVP, Head of Corporate DevelopmentPast Role: NodThera, President & CEO
- Philippe Hébrard: Head of Product - Biogen Digital Health
About the Company
Biogen is a biotechnology company engaged in the development of innovative therapies for neurological and neurodegenerative diseases. Biogen is developing a pipeline of possible medicines in neurology, neuropsychiatry, specialized immunology, and rare illness, and the company is laser-focused on its mission of helping humanity through science and
building a healthier, more sustainable, and equitable world.
